Chemical Structure : Atractylenolide I
CAS No.: 73069-13-3
货号: PC-27935Not For Human Use, Lab Use Only.
Atractylenolide I (ATT-I, AT-I) is a sesquiterpene derived from the rhizome of Atractylodes macrocephala within neuroprotective, anti-allergic, anti-inflammatory and anticancer properties, targets and binds proteasome 26S subunit non-ATPase 4 (PSMD4) with MST KD of 0.4 uM, enhances antigen presentation on tumor cells.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | ¥980 | In stock | |
| 25 mg | ¥1580 | In stock | |
| 50 mg | ¥2580 | In stock | |
| 100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Atractylenolide I (ATT-I, AT-I) is a sesquiterpene derived from the rhizome of Atractylodes macrocephala within neuroprotective, anti-allergic, anti-inflammatory and anticancer properties, targets and binds proteasome 26S subunit non-ATPase 4 (PSMD4) with MST KD of 0.4 uM, enhances antigen presentation on tumor cells.
Atractylenolide I (ATT-I) promotes CD8+ T cell–mediated tumor cell killing.
Atractylenolide I (ATT-I) enhances the antigen-specific T cell responses in MC38 tumor–derived organoids.
Atractylenolide I (ATT-I) promotes the activity of immunoproteasome in a PSMD4-dependent manner, binds to PSMD4 and stabilizes the PSMD4 and PSMD7 interaction, leading to enhanced proteasomal activities.
Atractylenolide I (ATT-I) promotes antigen presentation and enhances the efficacy of CRC immunotherapy.
Atractylenolide I (ATT-I) enhances tumor-infiltrating lymphocytes and antitumor activity of cytotoxic T lymphocytes.
| 分子量 | 230.31 | |
| 分子式 | C15H18O2 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
(4aS,8aS)-3,8a-Dimethyl-5-methylene-4a,5,6,7,8,8a-hexahydronaphtho[2,3-b]furan-2(4H)-one |
|
1. Xu H, et al. J Clin Invest. 2026 May 1;136(9):e208647.
2. Miao Y, et al. iScience. 2026 Aug 21;29(9):117259.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright